Collegium Pharmaceutical Inc. COLL
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Collegium Pharmaceutical is a specialty biopharmaceutical company focused on developing and commercializing medicines for pain management and neuropsychiatric conditions. The company's primary portfolio includes Jornay PM, a central nervous system stimulant for attention deficit hyperactivity disorder; Belbuca, a bucca…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees357
TickerCOLL
Statistics
Market Cap$1.09B
Revenue (TTM)$780.6M
Net Income$62.9M
Net Margin8.1%
EPS$1.73
P/E16.89
P/S1.42
P/B3.61
EV/EBITDA3.85
ROE27.4%
Dividend Yield—
Price$33.50
Data: Twelve Data · Revenue = mcap / P/S